文献速递妇科生殖医学

DNA甲基化与miRNA表达改变:阐释多囊卵巢综合征病理生理学的表观遗传标记

Altered DNA methylation and miRNA expression: epi-marks for elucidating the pathophysiology of PCOS.
PubMed 文献 · Reprod Biomed Online · 2025-01-23

本文综述多囊卵巢综合征(PCOS)的表观遗传学研究进展,重点总结全基因组及组织特异性DNA甲基化改变和微小RNA(miRNA)表达变化,并讨论这些表观遗传改变与PCOS代谢及卵巢功能失调的关联,为阐释其病理生理机制提供线索。

要点

  • PCOS是一种影响育龄女性的复杂异质性内分泌疾病,以排卵障碍、高雄激素表现、多囊卵巢形态及生育力受损为特征。
  • PCOS还伴随胰岛素抵抗、肥胖、高血压、2型糖尿病和心血管疾病等代谢紊乱及相关共病风险升高。
  • DNA甲基化和miRNA表达改变与PCOS代谢及卵巢调控异常相关,支持表观遗传在PCOS发病中的作用。

核心结论

  • DNA甲基化和miRNA表达改变等表观遗传机制参与调控组织特异性基因表达,并可能触发PCOS的发生发展。

研究设计与样本

  • 本文为综述,聚焦DNA甲基化与miRNA表达改变在PCOS病理生理学中的研究进展。

主要发现

  • PCOS患者存在全基因组和组织特异性DNA甲基化及miRNA表达模式的改变。
  • 许多表观遗传改变与PCOS相关的代谢失调和卵巢功能失调相关联。

关键数值与推荐

  • PCOS以稀发或闭经、临床和生化高雄激素表现、超声多囊卵巢形态及生育力受损为特征。
  • PCOS与胰岛素抵抗、肥胖、高血压、2型糖尿病和心血管疾病等代谢紊乱及相关共病风险升高相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrinopathy affecting women of reproductive age. This multifactorial disorder is characterized by oligo- or amenorrhoea, clinical and biochemical signs of hyperandrogenism, polycystic ovarian morphology on ultrasound, and impaired fertility. Beyond reproductive challenges, PCOS is associated with elevated risks of metabolic disturbances and associated comorbidities including insulin resistance, obesity, hypertension, type 2 diabetes and cardiovascular diseases. Despite extensive research, the pathophysiology of PCOS remains elusive. Advances in high-throughput sequencing and molecular biology techniques reflect the tandem influence of both genetic and epigenetic factors in its pathogenesis. Notably, the absence of strong genetic determinants and growing evidence implicating intrauterine and lifestyle-associated factors strongly support the epigenetic model of inheritance and development of PCOS. The epigenetic machinery, through mechanisms including DNA and RNA methylation and histone modifications, regulates gene expression and chromatin structure. Recent studies have identified small non-coding RNA and particularly microRNAs (miRNAs) as additional epigenetic components that modulate transcriptional silencing by interacting with target mRNA. Together, these epigenetic mechanisms impact tissue-specific gene expression patterns and, hence, potential to trigger disease development. Changes in global and tissue-specific DNA methylation and miRNA expression patterns have been studied extensively in the context of the pathophysiology of PCOS. Many of these changes have been linked to metabolic and ovarian dysregulation associated with this condition. This review highlights recent advances in understanding the epigenetic landscape of PCOS, focusing on DNA methylation and changes in miRNA expression, and discusses their implications on mechanisms underlying the development of PCOS.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Bhingardeve S, Sagvekar P, Mukherjee S, et al. Altered DNA methylation and miRNA expression: epi-marks for elucidating the pathophysiology of PCOS. Reprod Biomed Online. 2025. PMID: 40446648. doi:10.1016/j.rbmo.2025.104838

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。